Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Fortress Biotech Inc FBIOP


Primary Symbol: FBIO

Healthcare Biotechnology
Fortress Biotech, Inc. is a biopharmaceutical company focused on acquiring and advancing assets. The Company has seven marketed prescription pharmaceutical products and over 25 programs in development at the Company, at its majority-owned and majority-controlled partners and subsidiaries and at partners and subsidiaries it founded and in which it holds significant minority ownership positions... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:FBIO)

Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

GlobeNewswire 10 days ago

Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

GlobeNewswire 10 days ago

Checkpoint Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Updates

GlobeNewswire 12 days ago

Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

GlobeNewswire 12 days ago

Mustang Bio Receives Positive Listing Determination from Nasdaq

GlobeNewswire 12 days ago

Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma

GlobeNewswire November 7, 2024

Journey Medical Corporation Announces U.S. FDA Approval of Emrosi(TM) (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea

GlobeNewswire November 4, 2024

Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference

GlobeNewswire October 25, 2024

Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds

GlobeNewswire October 24, 2024
View More News ››

Opinion & Analysis (NDAQ:FBIO)

Understanding Fortress Biotech

Streetwise Reports February 6, 2020

Coverage Initiated on 'Biotech Machine'

Streetwise Reports September 5, 2019

Coverage Initiated on Biopharma With 'Low Risk/High Margin Assets'

Streetwise Reports July 6, 2019

2018 Biotech Watchlist: 'no one space is going to dominate'

Streetwise Reports January 11, 2018
View More Opinion ››

Bullboard Posts (NDAQ:FBIO)

Journey Medical Corporation Appoints Michael C. Pearce to Bo

Just In: $FBIO Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors | BenzingaSCOTTSDALE, Ariz., July 11, 2024...
whytestocks - July 11, 2024

Journey Medical Corporation Appoints Michael C. Pearce to Bo

Just In: $FBIO Journey Medical Corporation Appoints Michael C. Pearce to Board of DirectorsSCOTTSDALE, Ariz., July 11, 2024 (GLOBE...
whytestocks - July 11, 2024

Fortress Biotech Announces Pause in Payment of Dividends on

NEWS: $FBIO Fortress Biotech Announces Pause in Payment of Dividends on 9.375% Series A Cumulative Redeemable Perpetual Preferred...
whytestocks - July 5, 2024

3 BIOTECH STOCKS INSIDERS ARE SELLING

3 BIOTECH STOCKS INSIDERS ARE SELLING $VERU $FBIO $SGMO Learn More https://www.aviseanalytics.com/3-biotech-stocks-insiders-are...
AviseAnalytics - August 26, 2021

BIG news -FBIO - Any time fly soon.

Fortress Biotech Prices Brokered Public Sale of Preferred Stocks at $18 Per Share 27 Aug 2020 07:59 ET   07:59 AM EDT, 08...
HugeMoney - August 27, 2020

it's a buy today for me

at $1.76 per share,so glta.
coolfooldumbguy - August 26, 2019
View more Bullboard ››

Revive Therapeutics Ltd

Revive Therapeutics Ltd

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of ...
View More »